Facing a challenging business landscape, Germany’s Bayer (ETR: BAYN) has announced a new operating model aimed at enhancing its performance and returning to profitable growth. The plan includes significant job cuts as part of an ongoing staff reduction program, with compulsory redundancies set to begin in 2027.
In contrast to previous discussions during the Q3 2023 earnings call, which suggested a possible separation of either the Consumer Health or Crop Science units, Bayer’s recent press release emphasizes that the “existing ONE Bayer structure” provides the most significant opportunities for the company’s employees moving forward.- Flcube.com
